Main activities Preclinical research and development in the field of cardiovascular disorders, neurodegenerative diseases, diabetes, vaccine development Comprehensive preclinical and toxicological service for human and veterinary pharmaceuticals, biological drugs, medical devices (PHARMA), food additives and chemicals and chemical preparations (REACH) Animal models of selected human diseases (cardiovascular, neurodegenerative, diabetes, ophthalmic, …) Animal breeding – accredited breeding facility (Rodents, dogs, non-human primates) Registration number: 104984/2010-17210 MediTox s.r.o. Celebrate with us the 15-year anniversary MediTox s.r.o. is a GLP-certified preclinical contract research organization offering a wide range of preclinical development services taking advantage of wealth of experience in variety of therapeutics areas, biotechnology, chemical and agrochemical industry and research collaboration with universities and research institutions. MediTox R&D activities are pointed to collaborative scientific and research projects within international and national framework. The strong points of MediTox ensure personalized and comprehensive contract research (one-stop-shop), high professional standard together with, flexibility and competitive pricing. CPHI Russia 2014, St. Petersburg, April 16 – 17, 2014 BioMed 2014 BIO 2014, San Diego, USA, June 23 – 26, 2014 CPHI/ICSE South America, Sao Paulo, Brazil, August 5 – 7, 2014 You can find us here contacts Company Overview Quality & Ethics Research Projects Experimental Services Breeding Facility Partnership Downloads Contacts Newsroom Photogalery select language cz en 中文 News New R&D projects © Copyright MediTox s.r.o. 2013 created by PRO-COMUNICATION s.r.o., design by oMicrone.net